US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Bumetanide Tablets

Reason Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.

Upsher Smith Laboratories, Inc. NDC 0832-0542-11 D-0281-2019
Class II · Moderate risk Terminated

Bumetanide Tablets

Reason Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.

Upsher Smith Laboratories, Inc. NDC 0832-0541-11 D-0280-2019
Class II · Moderate risk Terminated

Elelyso

Reason Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.

Pfizer Inc. NDC 0069-0106-01 D-0005-2019
Class II · Moderate risk Terminated

SparkleFresh Fluoride Toothpaste

Reason Microbial Contamination of Non-Sterile Product

Medline Industries Inc NDC 53329-083-92 D-0247-2019
Class II · Moderate risk Terminated

Lamotrigine Extended-Release Tablets

Reason Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.

Torrent Pharma Inc. D-1204-2018
Class II · Moderate risk Terminated

Zinc Sulfate 1 mg/mL MDV Injectable

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1418-10 D-0212-2019